Brief: Xbrane Biopharma Q3 EBITDA Widens To SEK 55.8 Mln

Xbrane Biopharma AB

13/11/2020 07:04

Nov 13 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * Q3 EBITDA WAS SEK -55.8 M (-35.6*)

Source text for Eikon:  ID:nMFN9dY6fd 
Further company coverage:  XBRANE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))